Sleep Apnea and Testosterone: Why Treating the Wrong Problem First Can Set You Back

A lot of men come to my clinic having already tried testosterone replacement therapy. They felt tired, their libido was down, the gym gains had plateaued — and a primary care workup showed low total testosterone. TRT seemed like the logical answer. Some felt better, at least for a while. But a meaningful number weren't getting the full benefit they expected. What frequently turns out to be missing from the picture is a diagnosis of obstructive sleep apnea — and an understanding of just how deeply untreated OSA can affect male hormonal health.

What Sleep Apnea Does to the Male Body

Obstructive sleep apnea (OSA) is more than a snoring problem. Every time the airway collapses during sleep, the body experiences a brief episode of oxygen deprivation — sometimes dozens or hundreds of times per night. These episodes trigger a full-scale stress response: cortisol and adrenaline surge, blood pressure spikes, the heart works harder, and the brain is jolted out of restorative sleep stages before the cycle repeats.

Over time, the cumulative effect of this nightly physiological stress touches nearly every system in a man's body:

Heart and blood vessels. Untreated OSA approximately doubles the risk of cardiovascular events. The combination of intermittent hypoxia, sympathetic nervous system activation, and endothelial dysfunction creates the ideal environment for hypertension, atrial fibrillation, and accelerated atherosclerosis. The Cardiovascular Health Study and multiple prospective cohorts have established OSA as an independent risk factor for major cardiac events — independent, meaning even after accounting for obesity, diabetes, and smoking.

Metabolism. The same nightly cortisol surges that disrupt sleep architecture also impair insulin sensitivity. OSA is strongly associated with metabolic syndrome, type 2 diabetes, and visceral adiposity — a particularly important connection because visceral fat contains high concentrations of aromatase, the enzyme that converts testosterone into estrogen. More abdominal fat, more aromatase activity, lower effective testosterone.

Brain and mood. Sleep fragmentation from OSA directly impairs prefrontal cortex function — the part of the brain responsible for executive function, decision-making, and emotional regulation. Untreated OSA is associated with depression, anxiety, and cognitive decline at rates that significantly exceed the general population. Many men describe a fog that they've adapted to as their baseline — only recognizing how impaired they were after effective treatment.

Reproductive health. A 2022 pilot study by Kyrkou et al. (Journal of Personalized Medicine, PMID 35743765) found that men with OSA had significantly impaired erectile function, reduced testosterone levels, and lower semen quality compared to controls. After one year of CPAP therapy, sexual function improved — a finding consistent with the growing evidence that erectile dysfunction in OSA is not purely hormonal but also involves vascular and autonomic mechanisms that respond to sleep normalization.

The Testosterone Connection — And Why It's More Complicated Than You Think

Testosterone is largely secreted during sleep. The peak of its diurnal rhythm occurs during slow-wave and REM sleep, with levels dropping throughout the day. When OSA fragments sleep architecture and suppresses restorative sleep stages, that nightly testosterone pulse is disrupted at its source.

The biology is well understood: intermittent hypoxia and sleep fragmentation suppress the hypothalamic-pituitary-gonadal (HPG) axis. Gonadotropin-releasing hormone (GnRH) release from the hypothalamus is reduced, luteinizing hormone (LH) pulses diminish, and Leydig cell stimulation in the testes falls — resulting in lower circulating testosterone. Additionally, the oxidative stress caused by recurrent hypoxemia appears to directly impair Leydig cell function.

So why doesn't treating OSA reliably restore testosterone to normal?

The answer, according to the research, is that the relationship is not a simple two-way street.

A 2019 meta-analysis by Cignarelli and colleagues (Frontiers in Endocrinology, PMID 31496991) pooled data from 12 studies and 388 patients and found that CPAP use was not associated with a statistically significant change in total testosterone levels. This is often quoted as evidence that OSA and testosterone are not directly related. But a 2022 review by Liu and Reddy (Reviews in Endocrine and Metabolic Disorders, PMID 36152143) — one of the most rigorous analyses of this literature — argues that conclusion is premature. The available CPAP studies are substantially underpowered, and better-designed studies point in a more hopeful direction: CPAP therapy, when used adherently, does appear to improve testosterone exposure and erectile function over time.

The nuance matters. A 2020 population study by Clarke et al. (European Journal of Endocrinology, PMID 32348955) found that after controlling for BMI, OSA was not an independent determinant of testosterone. This doesn't mean OSA doesn't matter for male hormonal health — it means that obesity is the dominant driver in this relationship, and OSA and low testosterone are often both downstream consequences of the same metabolic dysfunction.

"The question I ask in clinic isn't 'does this man have low testosterone?' — it's 'why does this man have low testosterone?' Sleep apnea, obesity, and hypogonadism form a triangle. You have to treat all three corners, not just the number on the lab report." — Dr. Vishal Saini, MD, FAASM

This has critical practical implications. Prescribing testosterone replacement therapy without first diagnosing and treating OSA is not just missing a root cause — it can actively make things worse. High-dose testosterone therapy is a known risk factor for worsening sleep-disordered breathing. TRT relaxes upper airway musculature and may alter the ventilatory control response, potentially converting mild OSA into severe OSA. A 2019 review by Kim and Cho (World Journal of Men's Health, PMID 29774669) explicitly recommends that TRT should be avoided in patients with severe untreated OSA, and that all patients should be screened for OSA symptoms before and after initiating testosterone therapy.

What This Means If You're a Man in Mid-Michigan Dealing With Fatigue, Low Libido, or Low T

If you've been told your testosterone is low, or if you've been struggling with fatigue, poor sleep, erectile dysfunction, or difficulty with weight despite reasonable effort — sleep apnea belongs in the differential. And it's far more common than most men realize.

OSA affects an estimated 15–30% of adult men, with rates significantly higher in those with obesity, metabolic syndrome, or a collar size over 17 inches. The majority remain undiagnosed.

At Mid-West Center for Sleep Disorders, we see men across the care spectrum: some come directly after a partner reports loud snoring or witnessed pauses in breathing; others arrive after years of TRT that hasn't delivered the results they expected; and still others are referred from urology or endocrinology after standard workup leaves the fatigue or hormonal picture unexplained.

For men in the Lansing area seeking sleep apnea treatment in Lansing, Michigan, our Lansing clinic offers comprehensive sleep studies including home sleep apnea testing and in-lab polysomnography — the gold standard for diagnosing OSA severity and ruling out co-existing sleep disorders that can look like hypogonadism on a lab panel.

Men in northern Michigan seeking sleep apnea treatment in Traverse City, Michigan can access the same diagnostic and treatment services at our Traverse City location, where we regularly see patients who've been managing fatigue and hormonal symptoms for years without a sleep evaluation.

We also serve patients seeking sleep apnea treatment in Eaton Rapids, Michigan at our Eaton Rapids location, providing sleep apnea diagnosis and management for men in that community who may not realize how close comprehensive sleep care is.

The Right Order of Operations

Based on the evidence, here's the clinical approach I recommend for men presenting with low testosterone symptoms:

Screen for OSA first. A simple home sleep test can rule out moderate-to-severe OSA in most cases. If OSA is present, it should be the first target of treatment.
Optimize weight and metabolic health in parallel. Weight loss — even modest amounts — has more consistent effects on testosterone than CPAP alone. A 10% reduction in body weight produces meaningful testosterone improvements in overweight men.
Give CPAP adherent use 3–6 months before reassessing hormones. Testosterone levels fluctuate significantly and should be re-checked under conditions of adequately treated sleep. Measuring testosterone while a man is still fragmented and hypoxic every night produces unreliable results.
Consider TRT only after OSA is treated. If testosterone remains low after effective sleep treatment and metabolic optimization, then hypogonadism is more likely to represent a primary or mixed androgen deficiency that may benefit from replacement therapy — but OSA should be monitored closely throughout.
Never treat suspected hypogonadism without a sleep history. If your doctor prescribes TRT without asking you a single question about your sleep, bring up OSA at your next appointment.

What We Don't Know Yet

The existing CPAP-testosterone literature has a significant design problem: most studies are short (6–12 weeks), use variable adherence thresholds, and don't account for concurrent metabolic changes or weight fluctuation. We don't yet have large, randomized controlled trials of adequate duration comparing CPAP alone, weight loss alone, and combined approaches on testosterone and androgen bioavailability.

What we do know is that the men who seem to recover the most hormonal ground are those who treat OSA aggressively, lose weight, exercise regularly, and optimize sleep duration — not those who rely on any single intervention in isolation.

The Bottom Line

Untreated obstructive sleep apnea disrupts testosterone production at its source, compounds the metabolic dysfunction that drives low androgen states, impairs erectile function through both vascular and hormonal mechanisms, and — if TRT is initiated without OSA treatment — can make the underlying sleep disorder substantially worse. The evidence for CPAP alone dramatically restoring testosterone is modest, but the case for treating OSA as the first step in men's hormonal health workup is strong. If you're a man struggling with fatigue, low libido, or a testosterone level that isn't responding to treatment, sleep apnea may be the piece of the puzzle that's been missed.

Dr. Vishal Saini, M.D., FAASM is the Research & Medical Director at Mid-West Center for Sleep Disorders, with locations in Lansing, Traverse City, and Eaton Rapids, Michigan. He specializes in rare sleep disorders, sleep medicine research, and complex sleep-related metabolic presentations.

Book a Consultation → | (517) 887-6733

References:

Kyrkou K et al. J Pers Med. 2022;12(6):980. (PMID 35743765)
Clarke BM et al. Eur J Endocrinol. 2020;183(1):31-39. (PMID 32348955)
Liu PY. J Clin Endocrinol Metab. 2019;104(10):4398-4417. (PMID 31042277)
Liu PY, Reddy RT. Rev Endocr Metab Disord. 2022;23(6):1323-1339. (PMID 36152143)
Cignarelli A et al. Front Endocrinol (Lausanne). 2019;10:551. (PMID 31496991)
Kim SD, Cho KS. World J Mens Health. 2019;37(1):12-18. (PMID 29774669)